News
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
8don MSN
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...
French drug regulators updated their recommendations for Ixchiq in April and the European Medicines Agency announced May 7 that its safety committee had launched a review of the vaccine and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results